Akouos
NEWS
Eli Lilly is acquiring precision medicine biotech Akouos for $487 million in cash in a deal focused on developing gene therapies for hearing loss.
The FDA has a broad range of activities in the drug and medical device space. Here’s a look at the agency’s work this week.
Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers
Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.
Biopharma and life sciences companies strengthen their leadership teams and boards with Movers & Shakers.
The 24th Annual meeting of the American Society of Gene & Cell Therapy presents cutting-edge work in the booming area of gene and cell therapy. Here’s a look at a few of the highlights.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Biopharma and life sciences companies strengthen their leadership teams and board with these Movers and Shakers.
Three months after hearing loss-focused company Akouos secured $105 million in a Series B financing round, the Boston-based company is eying an initial public offering valued at about $100 million.
JOBS
IN THE PRESS